5 Drug Stores Stocks With The Highest Revenue Estimates

Below are the top drug stores stocks in terms of revenue estimate for the current year. Analysts expect CVS Caremark

to post revenue of $122.80 billion for the year ending December, 2012. CVS Caremark's trailing-twelve-month revenue is $116.50 billion. Walgreen Co

is expected to report revenue of $71.73 billion for the year ending August, 2012. Walgreen's trailing-twelve-month revenue is $72.53 billion. Rite Aid

is likely to post revenue of $25.42 billion in the year ending February, 2013. Rite Aid's trailing-twelve-month revenue is $26.20 billion. GNC Holdings

may report revenue of $2.43 billion in the year ending December, 2012. GNC Holdings' trailing-twelve-month revenue is $2.29 billion. PharMerica

is estimated to post revenue of $1.84 billion in the year ending December, 2012. PharMerica's trailing-twelve-month revenue is $1.97 billion.